MAPK1 and lysosomal storage disease: These findings suggest that inhibition of mTOR, LAT, PI3K, AKT, JNK, RIP3K, ERK, MAP3K1, and p38MAPK- signaling can stop the neuroinflammation in lysosomal storage diseases.